

Most read
- Huntington Hammer Holds on to Defeat Canton
- MU Graduation
- Huntington St. Joe Women Take Third State Basketball Title
- Scrimmages Make Up Green and White Game
- REEL LIFE February 18 and Beyond
- Huntington Hammer Falls to Kentucky's River Monsters
- Marshall Tops UCF in Final Home Game
- CNN Reporter & Marshall Alum Inspires Honors Students to Ethically Reach for Greatness by Challenging the Facts
Marshall University researcher receives NIH grant for research on myocardial infarction

Pierre received a $440,000 three-year NIH Research Enhancement Award (R15), designed to support small-scale research projects that strengthen the research environment of the institution. Through the grant, Pierre and her team will explore a new Na/K-ATPase/Src pathway as a target in ischemia/reperfusion injury to limit cardiac dysfunction in hopes of developing new therapeutic interventions for the treatment of myocardial infarction and heart failure.
Myocardial infarction remains the leading cause of mortality in industrialized nations, accounting for nearly 1 in 3 deaths in the United States, and resulting in significant disability among survivors. The study will test two distinct interventions in both the acute phase of myocardial infarction as well as the chronic phase of adverse cardiac remodeling, the phase which ultimately leads to heart failure in the growing number of individuals who survive a heart attack.
This study will build on Pierre’s previous research that identified the cardioprotective properties of Na/K-ATPase signaling pathway in the cardiac myocyte.